Retatrutide subcutaneous injections involve less depth, smaller volumes per injection, and no immune-triggering adjuvants
That monitoring is what makes their concurrent use clinically manageable the care team can assess how each treatment is performing, identify any relevant interactions, and adjust accordingly
(PubMed) Stewart ZA, Westfall MD, Pietenpol JA
The use of GLP-1RA for the treatment of central nervous system disorders is considered promising, but it is still insufficiently studied
Here's the science bit: drugs like Ozempic, WeGovy and Mounjaro work as GLP-1 agonists - essentially, they mimic the effects of our natural GLP-1 production, meaning they can help treat obesity and conditions such as diabetes, and insulin sensitivities such as polycystic ovarian syndrome (PCOS)